By Rishika Sadam May 5 (Reuters) - Biocon founder and chairperson Kiran Mazumdar-Shaw plans a gradual leadership transition ...
Verana Health ®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world ...
NKTR looks de-risked after positive Rezpeg phase 2 data in atopic dermatitis & alopecia areata, with 80% upside and $1.1B ...
The questionnaire considers postoperative management, patient health status, and tumor-specific features to compare risks and ...
The market is pricing in a grim future, but the company reaffirmed 2026 revenue and adjusted EPS guidance and just declared a ...
Explore how stable cash flows and strategic shifts support dividend stocks despite market volatility, highlighting resilience ...
Biocon founder Kiran Mazumdar-Shaw has named her niece, Bicara Therapeutics CEO Claire Mazumdar, as her chosen successor in a ...
Shield Therapeutics plc ( SHIEF) Q1 2026 Sales/Trading Call May 5, 2026 9:15 AM EDT ...
The Global Disposable Ostomy Bags Market is witnessing consistent expansion, fueled by rising incidences of colorectal ...
Pfizer updated its commercial structure in Q1 2026 by moving certain off-patent branded products, generic sterile injectables, and biosimilars from its Specialty Care and Oncology portfolios into a ...
On 29 April 2026, BeOne Medicines announced that the FDA granted Priority Review to an sBLA for TEVIMBRA with ZIIHERA and chemotherapy, alongside Breakthrough Therapy Designation for ZIIHERA-based ...
17hon MSNOpinion
Why Champions League can't tell us much about Premier League
It's easy to watch PSG and Bayern Munich light it up in the Champions League and lament that Premier League teams aren't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results